Machine learning microfluidic based platform: Integration of Lab-on-Chip devices and data analysis algorithms for red blood cell plasticity evaluation in Pyruvate Kinase Disease monitoring

• Published in: Sensors and actuators. A. Physical. Vol. 351; p. 114187
• Main Authors: Mencattini, A., Rizzuto, V., Antonelli, G., Di Giuseppe, D., D’Orazio, M., Filippi, J., Comes, M.C., Casti, P., Vives Corrons, J.L., Garcia-Bravo, M., Segovia, J.C., del Mar Mañú-Pereira, Maria, Lopez-Martinez, M.J., Samitier, J., Martinelli, E.
• Format: Journal Article
• Language: English
• Published: Elsevier B.V 01.03.2023
• Subjects: Blood disease; Deep transfer learning; Machine learning microfluidics; Video analysis; Video analysis; Blood disease; Machine learning microfluidics; Deep transfer learning
• ISSN: 0924-4247; 1873-3069
• DOI: 10.1016/j.sna.2023.114187

Microfluidics represents a very promising technological solution for conducting massive biological experiments. However, the difficulty of managing the amount of information available often precludes the wide potential offered. Using machine learning, we aim to accelerate microfluidics uptake and lead to quantitative and reliable findings. In this work, we propose complementing microfluidics with machine learning (MLM) approaches to enhance the diagnostic capability of lab-on-chip devices. The introduction of data analysis methodologies within the deep learning framework corroborates the possibility of encoding cell morphology beyond the standard cell appearance. The proposed MLM platform is used in a diagnostic test for blood diseases in murine RBC samples in a dedicated microfluidics device in flow. The lack of plasticity of RBCs in Pyruvate Kinase Disease (PKD) is measured massively by recognizing the shape deformation in RBCs walking in a forest of pillars within the chip. Very high accuracy results, far over 85 %, in recognizing PKD from control RBCs either in simulated and in real experiments demonstrate the effectiveness of the platform. [Display omitted] •We propose a machine learning approach to increase the patient stratification capability of laboratory-on-chip devices.•The proposed MLM platform exploited deep learning encoding cell morphology beyond the standard cell appearance.•Very high accuracy results have been obtained in the characterization of RBC cells Pyruvate Kinase Disease.